𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A selection system for human apoptosis inhibitors using yeast

✍ Scribed by Greenhalf, William; Lee, Janet; Chaudhuri, Bhabatosh

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
457 KB
Volume
15
Category
Article
ISSN
0749-503X

No coin nor oath required. For personal study only.

✦ Synopsis

Apoptosis is a regulated series of events which leads to the death and elimination of mammalian cells during development or in disease control. It is regulated in part by members of the Bcl-2 family of genes. Some of these stimulate cell death, while others prevent it. Expression of one of these death inducers, Bax-(Bax), in the yeast Saccharomyces cerevisiae induces growth arrest and subsequently can cause cell death. Proteins of the Bcl-2 family that are known to inhibit apoptosis in mammalian cells overcome Bax-induced growth arrest in yeast. We describe here a system for isolation of human genes that are able to overcome Bax sensitivity in yeast. Two novel proteins, identified with this system, have been named 'Bax antagonists selected in saccharomyces (BASS). These proteins not only overcome toxicity of Bax in yeast but also protect mammalian cells from apoptosis that is induced by staurosporine or Bax overexpression. We find that BASS2 is the more effective of the two genes.

πŸ“œ SIMILAR VOLUMES

UV-induced mutagenesis of human p53: Ana
UV-induced mutagenesis of human p53: Analysis using a double-selection method in yeast
✍ Deborah J. Moshinsky; Gerald N. Wogan πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 78 KB

Comparison of the mutation patterns of p53 in human tumors with those of selectable genes in model systems is a powerful approach to identify potential etiological factors for specific tumor types. Recently, we validated use of a yeast assay to permit direct determination of the mutation spectrum in

Gefitinib, a selective EGFR tyrosine kin
Gefitinib, a selective EGFR tyrosine kinase inhibitor, induces apoptosis through activation of Bax in human gallbladder adenocarcinoma cells
✍ Hiroshi Ariyama; Baoli Qin; Eishi Baba; Risa Tanaka; Kenji Mitsugi; Mine Harada; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 355 KB

## Abstract Although gefitinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, has been clinically demonstrated to be effective for certain cancer cell types, the molecular mechanisms of the anti‐tumor activity have not been fully elucidated. In this study, we inv